Guardian Pharmacy Services Reports Strong Q1 2025 Results

Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) has released its Q1 earnings. Here is a breakdown of the information Guardian Pharmacy Services, Inc. Class A presented to its investors.

Guardian Pharmacy Services, Inc. is a leading long-term care pharmacy services company that offers technology-enabled services to help residents of long-term health care facilities adhere to their medication regimens, thereby reducing care costs and improving clinical outcomes. The company operates across 38 states, serving approximately 189,000 residents in 7,000 facilities.

Guardian Pharmacy Services reported a strong financial performance for the first quarter of 2025, with significant growth in revenue and resident count. The company achieved a 20% year-over-year increase in revenue, reaching $329.3 million, driven by organic growth and strategic acquisitions. The resident count rose by 15% year-over-year, totaling 189,000 by the end of the quarter.

Key financial metrics for the quarter included a net income of $9.3 million, marking an increase of $2.2 million from the previous year. The adjusted EBITDA also saw a 16% rise to $23.4 million, despite incurring $1.0 million in costs associated with operating as a public company. The company maintained a strong cash position with $14.0 million in cash and cash equivalents and no long-term debt.

Looking forward, Guardian Pharmacy Services remains optimistic about its growth trajectory for the remainder of 2025. The company reaffirmed its full-year revenue guidance of $1.330 billion to $1.350 billion and adjusted EBITDA guidance of $97 million to $101 million. Management is focused on delivering organic growth and integrating new acquisitions to achieve profitability benchmarks, aiming to drive value for shareholders.